Fine Foods & Pharmaceuticals N.T.M. S.p.A.

DB:9S5 Stock Report

Market Cap: €219.4m

Fine Foods & Pharmaceuticals N.T.M Past Earnings Performance

Past criteria checks 2/6

Fine Foods & Pharmaceuticals N.T.M's earnings have been declining at an average annual rate of -41.6%, while the Life Sciences industry saw earnings growing at 13.9% annually. Revenues have been growing at an average rate of 10.6% per year. Fine Foods & Pharmaceuticals N.T.M's return on equity is 2%, and it has net margins of 1.1%.

Key information

-41.6%

Earnings growth rate

-36.1%

EPS growth rate

Life Sciences Industry Growth26.8%
Revenue growth rate10.6%
Return on equity2.0%
Net Margin1.1%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Fine Foods & Pharmaceuticals N.T.M makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:9S5 Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 242473460
31 Mar 24252-4460
31 Dec 23252-4450
30 Sep 232401430
30 Jun 23234-5420
31 Mar 23222-4400
31 Dec 22207-10390
30 Sep 22203-10390
30 Jun 22196-1380
31 Mar 22194-6360
31 Dec 21195-1350
30 Sep 21198-1350
30 Jun 212002340
31 Mar 2119013330
31 Dec 2017713310
30 Sep 201628280
30 Jun 20153-1270
31 Mar 20157-2280
31 Dec 19161-3280
30 Sep 191578290
30 Jun 191539290
31 Mar 191479280
31 Dec 181409260

Quality Earnings: 9S5 has high quality earnings.

Growing Profit Margin: 9S5 became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 9S5's earnings have declined by 41.6% per year over the past 5 years.

Accelerating Growth: 9S5 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 9S5 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Life Sciences industry (-9.9%).


Return on Equity

High ROE: 9S5's Return on Equity (2%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies